Cargando…
Incidence of high chromogranin A serum levels in patients with non metastatic prostate adenocarcinoma
BACKGROUND: ChromograninA in prostate carcinoma (PC) indicate NE differentiation. This tumour is more aggressive and resistant to hormone therapy. PATIENTS AND METHODS: We analyzed the incidence of pre-operative ChromograninA serum levels in non metastatic PC patients. Serum PSA and ChromograninA we...
Autores principales: | Appetecchia, Marialuisa, Meçule, Aurela, Pasimeni, Giuseppe, Iannucci, Concetta V, De Carli, Piero, Baldelli, Roberto, Barnabei, Agnese, Cigliana, Giovanni, Sperduti, Isabella, Gallucci, Michele |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018395/ https://www.ncbi.nlm.nih.gov/pubmed/21162758 http://dx.doi.org/10.1186/1756-9966-29-166 |
Ejemplares similares
-
Indirect Basal Metabolism Estimation in Tailoring Recombinant Human TSH Administration in Patients Affected by Differentiated Thyroid Cancer: A Hypothesis-Generating Study
por: Barnabei, Agnese, et al.
Publicado: (2018) -
Testicular and inguinal lymph node metastases of medullary thyroid cancer: a case report and review of the literature
por: Appetecchia, Marialuisa, et al.
Publicado: (2014) -
Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives
por: Appetecchia, Marialuisa, et al.
Publicado: (2010) -
Specific and Non-Specific Biomarkers in Neuroendocrine Gastroenteropancreatic Tumors
por: Sansone, Andrea, et al.
Publicado: (2019) -
Endocrine Toxicities of Antineoplastic Therapy: The Adrenal Topic
por: Barnabei, Agnese, et al.
Publicado: (2022)